1. Home
  2. DBVT vs HVT Comparison

DBVT vs HVT Comparison

Compare DBVT & HVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • HVT
  • Stock Information
  • Founded
  • DBVT 2002
  • HVT 1885
  • Country
  • DBVT France
  • HVT United States
  • Employees
  • DBVT N/A
  • HVT N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • HVT Other Specialty Stores
  • Sector
  • DBVT Health Care
  • HVT Consumer Discretionary
  • Exchange
  • DBVT Nasdaq
  • HVT Nasdaq
  • Market Cap
  • DBVT 239.9M
  • HVT 290.0M
  • IPO Year
  • DBVT N/A
  • HVT N/A
  • Fundamental
  • Price
  • DBVT $8.35
  • HVT $20.96
  • Analyst Decision
  • DBVT Buy
  • HVT
  • Analyst Count
  • DBVT 4
  • HVT 0
  • Target Price
  • DBVT $14.81
  • HVT N/A
  • AVG Volume (30 Days)
  • DBVT 102.2K
  • HVT 125.0K
  • Earning Date
  • DBVT 07-29-2025
  • HVT 04-30-2025
  • Dividend Yield
  • DBVT N/A
  • HVT 6.11%
  • EPS Growth
  • DBVT N/A
  • HVT N/A
  • EPS
  • DBVT N/A
  • HVT 1.28
  • Revenue
  • DBVT $3,497,000.00
  • HVT $720,469,000.00
  • Revenue This Year
  • DBVT $1,700.53
  • HVT $4.96
  • Revenue Next Year
  • DBVT $535.67
  • HVT $8.28
  • P/E Ratio
  • DBVT N/A
  • HVT $16.36
  • Revenue Growth
  • DBVT N/A
  • HVT N/A
  • 52 Week Low
  • DBVT $2.21
  • HVT $17.01
  • 52 Week High
  • DBVT $12.78
  • HVT $29.85
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 42.98
  • HVT 58.10
  • Support Level
  • DBVT $8.33
  • HVT $19.94
  • Resistance Level
  • DBVT $9.92
  • HVT $21.35
  • Average True Range (ATR)
  • DBVT 0.92
  • HVT 0.53
  • MACD
  • DBVT -0.32
  • HVT 0.02
  • Stochastic Oscillator
  • DBVT 4.53
  • HVT 71.83

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About HVT Haverty Furniture Companies Inc.

Haverty Furniture Companies Inc is a specialty retailer of residential furniture and accessories. It provides various products such as Sofa Tables, Sleepers, End Tables, Cocktail Tables, Accent Pieces, Display Cabinets, Wall Decor, floral and Tress, and other related products. The company operates in the Southern and Midwestern U.S. All its activities are encompassed in its Merchandise division. The company derives the majority of its revenue from its upholstery products and, secondarily, from bedroom furniture.

Share on Social Networks: